---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-23-005046"
form_type: "8-K"
ticker: null
cik: "0001293310"
company_name: "HUMANIGEN, INC"
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T04:57:36.029727+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Humanigen receives additional Nasdaq delisting notice for MVLS non-compliance; hearing held April 6

## Summary
- Nasdaq notified Humanigen on April 5 that it failed to meet minimum $35M MVLS requirement as of April 3.
- Company requested a 180-day extension until Aug 21, 2023 at hearing on April 6; Panel decision expected within 30 days.
- Trading suspension stayed pending hearing process and any extension granted, up to 180 days from Feb 21, 2023.
- Non-compliance also involves bid price below $1.00 and stockholders' equity requirements for Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001214659-23-005046
- form_type: 8-K
- cik: 0001293310
- company_name: HUMANIGEN, INC
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1293310/000121465923005046/0001214659-23-005046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1293310/000121465923005046/g462338k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-23-005046
- JSON: https://secwatch.observer/filing/0001214659-23-005046.json
- Plain text: https://secwatch.observer/filing/0001214659-23-005046.txt

## Key facts
- Listing & Compliance Notices
  HUMANIGEN, INC received a nasdaq delisting notice notice regarding market value.
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: market value
  source text: April 5, 2023, prior to the Hearing, the Company received a letter from the Nasdaq Staff notifying the Company that it had not regained compliance with the minimum MVLS requirement as of April 3, 2023 and that this deficiency would serve as an additional basis for delisting the Company’s securities from Nasdaq. The Nasdaq Staff’s letter also informed the Company that the Panel would consider, and the Company should address, this additional deficiency at the Hearing. At the Hearing held before the Panel on April 6, 2023, the Company outlined its plans for regaining compliance with the minimum b
  evidence_url: https://www.sec.gov/Archives/edgar/data/1293310/000121465923005046/0001214659-23-005046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.